Nine Entertainment Co Holdings Ltd

FY18 Outlook: Nine Entertainment Co Holdings Ltd (ASX: NEC) seems to be sticking to its FY18 group EBITDA guidance to be at the upper end of the range of analysts’ forecasts of $204m to $230m. Moreover, FY18 dividend is expected to be around 9.5 cents, consistent with FY17. From FY19, NEC expects the dividends to be in the 50-70% of NPAT range. Meanwhile, NEC stock has risen 1.33% in three months as on January 19, 2018, and was up 6.88% on January 22, 2018 while Fairfax Media and Domain Holdings were plunging. The group will release its FY18 interim results on 22 February 2018. As of now, we give a “Hold” recommendation on the stock at the current price of $1.63
 

FY 17 Financial Performance (Source: Company Reports)
 

Australian Pharmaceutical Industries Ltd

2018 half-year profit to be down 9%:Australian Pharmaceutical Industries Ltd (ASX: API) stock fell 3.6% on January 22, 2018 after the company flagged to expect 2018 half-year profit to be down 9% compared to the prior corresponding period, on account of soft retail conditions witnessed by its Priceline Pharmacy network. API now expects its half year 2018 net profit after tax (NPAT) to be approximately $26.5 million. However, the company expects that its full year NPAT to be marginally above that of FY17. Moreover, overall network sales, including dispensary, for the financial year to date is up 2% but the like-for-like front-of-store sales in its network had fallen 2.4% for the period. Additionally, the dividend payment for the first half is expected to be in line with the prior corresponding period. API has confirmed that its balance sheet and cash flow position still remain strong. Based on the foregoing, we give a “Hold” recommendation on the stock at the current price of $1.475

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.